Pulmonary Hypertension as a Risk Factor for Death in Patients with Sickle Cell Disease
The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Abstract
BACKGROUND: The prevalence of pulmonary hypertension in adults with sickle cell disease, the mechanism of its development, and its prospective prognostic significance are unknown. METHODS: We performed Doppler echocardiographic assessments of pulmonary-artery systolic pressure in 195 consecutive patients (82 men and 113 women; mean [+/-SD] age, 36+/-12 years). Pulmonary hypertension was prospectively defined as a tricuspid regurgitant jet velocity of at least 2.5 m per second. Patients were followed for a mean of 18 months, and data were censored at the time of death or loss to follow-up. RESULTS: Doppler-defined pulmonary hypertension occurred in 32 percent of patients. Multiple logistic-regression analysis, with the use of the dichotomous variable of a tricuspid regurgitant jet velocity of less than 2.5 m per second or 2.5 m per second or more, identified a self-reported history of cardiovascular or renal complications, increased systolic blood pressure, high lactate dehydrogenase levels (a marker of hemolysis), high levels of alkaline phosphatase, and low transferrin levels as significant independent correlates of pulmonary hypertension. The fetal hemoglobin level, white-cell count, and platelet count and the use of hydroxyurea therapy were unrelated to pulmonary hypertension. A tricuspid regurgitant jet velocity of at least 2.5 m per second, as compared with a velocity of less than 2.5 m per second, was strongly associated with an increased risk of death (rate ratio, 10.1; 95 percent confidence interval, 2.2 to 47.0; P<0.001) and remained so after adjustment for other possible risk factors in a proportional-hazards regression model. CONCLUSIONS: Pulmonary hypertension, diagnosed by Doppler echocardiography, is common in adults with sickle cell disease. It appears to be a complication of chronic hemolysis, is resistant to hydroxyurea therapy, and confers a high risk of death. Therapeutic trials targeting this population of patients are indicated.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Patients with higher rates of hemolysis have lower steady-state Hb levels and are more likely to develop vascular injury and organ dysfunction as they age, manifesting as pulmonary hypertension, diastolic left heart disease, and renal dysfunction (proteinuria, albuminuria, and chronic kidney dysfunction) (62, 64, 65, 70, 79).”
From Pathophysiology of Sickle Cell Disease (2019) · cites this paper as [64]
Citations
Cites
Recommendations for Quantitation of the Left Ventricle by Two-Dimensional Echocardiography
Schiller, N. B., Shah, P. M., Crawford, M., DeMaria, A., Devereux, R., Feigenbaum, H., Gutgesell, H., Reichek, N., Sahn, D., Schnittger, I., et al. (1989) · Journal of the American Society of Echocardiography · doi:10.1016/s0894-7317(89)80014-8 · Cited by 8,121
Mortality in sickle cell disease. Life expectancy and risk factors for early death
Platt, O. S., Brambilla, D. J., Rosse, W. F., Milner, P. F., Castro, O., Steinberg, M. H., & Klug, P. P. (1994) · New England Journal of Medicine · doi:10.1056/nejm199406093302303 · Cited by 3,320
Self-citationQuiñones, M. A., Otto, C. M., Stoddard, M., Waggoner, A., & Zoghbi, W. A. (2002) · Journal of the American Society of Echocardiography · doi:10.1067/mje.2002.120202 · Cited by 2,130
Adams, R. J., McKie, V. C., Hsu, L., Files, B., Vichinsky, E., Pegelow, C., Abboud, M., Gallagher, D., Kutlar, A., Nichols, F. T., et al. (1998) · New England Journal of Medicine · doi:10.1056/nejm199807023390102 · Cited by 1,866
De Caterina, R., Libby, P., Peng, H. B., Thannickal, V. J., Rajavashisth, T. B., Gimbrone, M. A., Shin, W. S., & Liao, J. K. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118074 · Cited by 1,782
Primary Pulmonary Hypertension
Rubin, L. J. (1997) · New England Journal of Medicine · doi:10.1056/nejm199701093360207 · Cited by 1,726
Cerebrovascular accidents in sickle cell disease: rates and risk factors.
(1998) · PubMed · doi:10.1182/blood.v91.1.288 · Cited by 1,694
Dams, R. O. J. A., Ie, V. I. C. M. C. K., Su, L. E. H., Iles, B. E. F., Ichinsky, E. L. V., Egelow, C. H. P., Bboud, M. I. A., Allagher, D. I. G., Utlar, K., Ichols, F. E. T. N., et al. (2015) · Cited by 1,338
Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease
Reiter, C. D., Wang, X., Tanus-Santos, J. E., Hogg, N., Cannon, R. O., Schechter, A. N., & Gladwin, M. T. (2002) · Nature Medicine · doi:10.1038/nm1202-799 · Cited by 1,330
Self-citationCell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease
Reiter, C. D., Wang, X., Tanus-Santos, J. E., et al. (2002) · Nature Medicine · doi:10.1038/nm799 · Cited by 1,097
Cited by
Items 701–800 of 999
Lorch, D. G., Spevack, D. M., & Little, J. A. (2011) · Acta Haematologica · doi:10.1159/000323464 · Cited by 15
TRV: A physiological biomarker in sickle cell disease
Kato, G. J. (2011) · Pediatric Blood & Cancer · doi:10.1002/pbc.23399 · Cited by 14
Ataga, K. I., Hinderliter, A. L., Brittain, J. E., Jones, S., Xu, H., Cai, J., Kim, S., Pritchard, K. A., & Hillery, C. A. (2014) · Hematology · doi:10.1179/1607845414y.0000000171 · Cited by 14
Filho, N. N. L., Figueiredo, M. S., Vicari, P., Cançado, R. D., Carvalho, A. C., Bordin, J. O., & Campos, O. (2014) · Echocardiography · doi:10.1111/echo.12853 · Cited by 14
Elevated Circulating Stromal-Derived Factor-1 Levels in Sickle Cell Disease
Landburg, P. P., Nur, E., Maria, N. I., Brandjes, D. P. M., Biemond, B. J., Schnog, J. B., & Duits, A. J. (2009) · Acta Haematologica · doi:10.1159/000243727 · Cited by 16
Zhang, Y., Belfer, I., Nouraie, M. S., Zeng, Q., Goel, R., Chu, Y., Krasiy, I., & Krishnamurti, L. (2018) · Journal of Pain Research · doi:10.2147/jpr.s149958 · Cited by 14
Morris, C. R., Kuypers, F. A., Hagar, R. W., Larkin, S. K., Lavrisha, L., Saulys, A., Vichinsky, E. P., & Suh, J. H. (2022) · Complementary Therapies in Medicine · doi:10.1016/j.ctim.2022.102803 · Cited by 18
Pulmonary Arterial Hypertension
Highland, K. B. (2008) · The American Journal of the Medical Sciences · doi:10.1097/maj.0b013e31815d2647 · Cited by 14
Hematopoietic Cell Transplantation for Hemoglobinopathies
Krishnamurti, L., Bunn, H. F., Williams, A. M., & Tolar, J. (2007) · Current problems in pediatric and adolescent health care · doi:10.1016/j.cppeds.2007.10.002 · Cited by 15
Advances in the management of sickle cell disease
Thompson, A. A. (2005) · Pediatric Blood & Cancer · doi:10.1002/pbc.20630 · Cited by 14
Sickle Cell Disease at the Dawn of the Molecular Era
Abboud, M. R., & Musallam, K. M. (2009) · Hemoglobin · doi:10.3109/03630260903347617 · Cited by 14
Derchi, G., & FORNI, G. L. (2005) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1345.070 · Cited by 14
Genetic Determinants of Wound Healing: Monogenic Disorders and Polygenic Influence
Mueller, S. M., Miller, N., Gill, J., Yu, L. C., PIKE, M. M., & Orgill, D. P. (2026) · Cells · doi:10.3390/cells15010074 · Cited by 18
Gladwin, M. T., Gordeuk, V. R., Desai, P. C., Minniti, C. P., Novelli, E. M., Morris, C. R., Ataga, K. I., Castro, L. D., Curtis, S. A., Rassi, F. A. E., et al. (2024) · The Lancet Haematology · doi:10.1016/s2352-3026(24)00045-0 · Cited by 15
Self-citationd’Humières, T., Sadraoui, Z., Savale, L., Boyer, L., Guillet, H., Alassaad, L., Luna, G. D., Iles, S., Balfanz, P., Habibi, A., et al. (2024) · Blood Advances · doi:10.1182/bloodadvances.2024013208 · Cited by 14
Kunz, J. B., & Tagliaferri, L. (2024) · Transfusion Medicine and Hemotherapy · doi:10.1159/000540149 · Cited by 16
Dahan, I., Farber, E., Thauho, N., Nakhoul, N., Francis, A., Awawde, M., Levy, A. P., Kim‐Shapiro, D. B., Basu, S., & Nakhoul, F. M. (2015) · Journal of Diabetes Research · doi:10.1155/2015/613860 · Cited by 15
Upadhya, B., Stacey, R. B., Ntim, W. O., Knovich, M. A., & Pu, M. (2014) · Acta Haematologica · doi:10.1159/000357393 · Cited by 13
PULMONARY HYPERTENSION IN CHILDREN WITH EVANS SYNDROME
Connor, P., Veys, P. A., Amrolia, P. J., Haworth, S. G., Ashworth, M. T., & Moledina, S. (2008) · Pediatric Hematology and Oncology · doi:10.1080/08880010801888253 · Cited by 13
Alkindi, S. S. A., Almufargi, S. S., & Pathare, A. V. (2019) · Experimental Biology and Medicine · doi:10.1177/1535370219892846 · Cited by 18
Pulmonary Complications of Sickle Cell Disease: A Narrative Clinical Review
Pervaiz, A., El‐Baba, F., Dhillon, K., Daoud, A., & Soubani, A. O. (2021) · Advances in respiratory medicine · doi:10.5603/arm.a2021.0011 · Cited by 15
Hematopoietic cell transplantation for sickle cell disease: updates and future directions
Krishnamurti, L. (2021) · Hematology · doi:10.1182/hematology.2021000251 · Cited by 17
Kassim, A. A., & Leonard, A. K. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11164775 · Cited by 13
Sickle Cell Disease Pathophysiology and Related Molecular and Biophysical Biomarkers
Saah, E. N., Fadaei, P., Gurkan, U. A., & Sheehan, V. (2022) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2022.06.005 · Cited by 16
d’Humières, T., Saba, J., Savale, L., Dupuy, M., Boyer, L., Guillet, H., Alassaad, L., Luna, G. D., Iles, S., D'Orengiani, A.-L. P. H. D., et al. (2023) · Blood · doi:10.1182/blood.2022019571 · Cited by 17
In search of the optimal iron chelation therapy for patients with thalassemia major
Berdoukas, V. A., & Wood, J. C. (2010) · Haematologica · doi:10.3324/haematol.2010.034397 · Cited by 13
Reproductive and contraceptive issues in chronically ill adolescents
Bacopoulou, F., Greydanus, D. E., & Chrousos, G. P. (2010) · The European Journal of Contraception & Reproductive Health Care · doi:10.3109/13625187.2010.532252 · Cited by 13
Pulmonary hypertension in children with sickle cell disease
Zuckerman, W. A., & Rosenzweig, E. B. (2011) · Expert Review of Respiratory Medicine · doi:10.1586/ers.11.6 · Cited by 13
Iron-induced remodeling in cultured rat pulmonary artery endothelial cells
Gorbunov, N. V., Atkins, J. L., Gurusamy, N., & Pitt, B. R. (2011) · BioMetals · doi:10.1007/s10534-011-9498-2 · Cited by 13
Alternative donor allogeneic hematopoietic cell transplantation for hemoglobinopathies
Alfraih, F. A., Aljurf, M. D., Fitzhugh, C. D., & Kassim, A. A. (2016) · Seminars in Hematology · doi:10.1053/j.seminhematol.2016.01.001 · Cited by 14
Atteintes pulmonaires au cours de la drépanocytose chez l’enfant
Pincez, T., Calamy, L., Germont, Z., Lemoine, A., Lopes, A., Massiot, A., Tencer, J., Thivent, C., & Hadchouel, A. (2016) · Archives de Pédiatrie · doi:10.1016/j.arcped.2016.06.014 · Cited by 14
A reappraisal of the mechanisms underlying the cardiac complications of sickle cell anemia
Rai, P., Niss, O., & Malik, P. (2017) · Pediatric Blood & Cancer · doi:10.1002/pbc.26607 · Cited by 14
Echocardiographic Screening of Cardiovascular Status in Pediatric Sickle Cell Disease
Allen, K. Y., Jones, S., Jackson, T., DeCost, G., Stephens, P., Hanna, B. D., Cohen, M. S., Smith‐Whitley, K., Mercer‐Rosa, L., & Natarajan, S. S. (2019) · Pediatric Cardiology · doi:10.1007/s00246-019-02202-3 · Cited by 14
Pulmonary Hypertension after Splenectomy in Hereditary Stomatocytosis
Yoshimoto, A., Fujimura, M., & Nakao, S. (2005) · The American Journal of the Medical Sciences · doi:10.1097/00000441-200510000-00008 · Cited by 13
Domiciliary Oxygen for Children
Balfour-Lynn, I. M. (2009) · Pediatric Clinics of North America · doi:10.1016/j.pcl.2008.10.010 · Cited by 13
Congestive Heart Failure and Treatment in Thalassemia Major
Aessopos, A., Kati, M., & Tsironi, M. (2008) · Hemoglobin · doi:10.1080/03630260701680839 · Cited by 13
Takatsuki, S., Ivy, D. D., & Nuss, R. (2011) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2011.09.015 · Cited by 14
Hematopoietic cell transplantation for sickle cell disease: state of the art
Krishnamurti, L. (2007) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.7.2.161 · Cited by 15
Longitudinal Analysis of Echocardiographic Abnormalities in Children With Sickle Cell Disease
Harrington, J. K., Krishnan, U., Jin, Z., Mardy, C., Kobsa, S., & Lee, M. T. (2017) · Journal of Pediatric Hematology/Oncology · doi:10.1097/mph.0000000000000930 · Cited by 13
Babalola, O. A., Chen, C. S., Brown, B. J., Cursio, J., Falusi, A. G., & Olopade, O. I. (2019) · Journal of Global Health Reports · doi:10.29392/joghr.3.e2019062 · Cited by 13
Self-citationSilva, M., & Faustino, P. (2023) · Antioxidants · doi:10.3390/antiox12111977 · Cited by 22
El-Shanshory, M. R., Ibrahim, B., Donia, A., Noha, E.-K., & Mokhtar, M. (2014) · Pediatric Blood & Cancer · doi:10.1002/pbc.25076 · Cited by 12
Thalassemia Major and Sickle Cell Disease in Adolescents and Young Adults
Yacobovich, J., & Tamary, H. (2014) · Acta Haematologica · doi:10.1159/000360235 · Cited by 12
Wonkam, A., Makani, J., Ofori-Acquah, S. F., Nnodu, O. E., Treadwell, M., Royal, C. D. M., & Ohene‐Frempong, K. (2015) · Cardiovascular journal of South Africa/Cardiovascular journal of Southern Africa · doi:10.5830/cvja-2015-040 · Cited by 14
A Growing Population of Older Adults with Sickle Cell Disease
Shet, A. S., & Thein, S. L. (2019) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2019.03.006 · Cited by 16
Fitzhugh, C. D., Volanakis, E. J., Idassi, O. M., Duberman, J. A., DeBaun, M. R., & Friedman, D. L. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11113118 · Cited by 14
Tantawy, A. A. G., Elsherif, N. H. K., Makkeyah, S. M. M., El‐Deen, N. S., Farghal, N. B. E., Soliman, N. M. S. E. D., & Ebeid, F. S. E. (2023) · Annals of Hematology · doi:10.1007/s00277-023-05099-4 · Cited by 15
Transthoracic Echocardiography and 6-Minute Walk Test in Kuwaiti Sickle Cell Disease Patients
Marouf, R., Behbehani, N., Zubaid, M., Wazzan, H. A., El-Muzaini, H., Abdulla, R., Mojiminiyi, O. A., & Adekile, A. D. (2014) · Medical Principles and Practice · doi:10.1159/000362126 · Cited by 14
Update in Pulmonary Vascular Diseases 2011
Hassoun, P. M., & Adnot, S. (2012) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201203-0377up · Cited by 12
Maioli, M. C. P., Soares, A. R., Bedirian, R., Alves, Ú. D., Marinho, C. D. L., & Lopes, A. J. (2015) · Revista Brasileira de Hematologia e Hemoterapia · doi:10.1016/j.bjhh.2015.11.001 · Cited by 12
Clinical Manifestations and Treatment of Adult Sickle Cell Disease
Costa, F. F., & Fertrin, K. Y. (2016) · Springer eBooks · doi:10.1007/978-3-319-06713-1_12 · Cited by 12
Correlates of Pulmonary Function in Children with Sickle Cell Disease and Elevated Fetal Hemoglobin
Adekile, A. D., Azab, A. F., Owayed, A. F., & Khadadah, M. E. (2017) · Medical Principles and Practice · doi:10.1159/000485801 · Cited by 12
Echocardiographic abnormalities in adolescent and adult Saudi patients with sickle cell disease
Aleem, A., Jehangir, A., Owais, M., Al-Momen, A., Al-Diab, A. I., Abdulkarim, H., & Alameri, H. F. (2007) · Saudi Medical Journal · doi:10.15537/1658-3175.3980 · Cited by 15
Successful Combined Heart and Kidney Transplantation in a Patient With Sickle-cell Anemia
Audard, V., Grimbert, P., Kirsch, M. E. W., Habibi, M. A., Lang, P., Remy, P., Abbou, C. C., Loisance, D. Y., Benaiem, N., Bachir, D., et al. (2006) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2006.04.001 · Cited by 12
Sleep and the Cardiovascular System in Children
Paul, G., & Pinto, S. J. (2017) · Sleep Medicine Clinics · doi:10.1016/j.jsmc.2017.01.004 · Cited by 13
PPARγ increases HUWE1 to attenuate NF-κB/p65 and sickle cell disease with pulmonary hypertension
Jang, A. J., Chang, S. S., Park, C., Lee, C., Benza, R. L., Passineau, M. J., Ma, J., Archer, D. R., Sutliff, R. L., Hart, C. M., et al. (2021) · Blood Advances · doi:10.1182/bloodadvances.2020002754 · Cited by 11
Kassim, A. A., & DeBaun, M. R. (2023) · Hematology · doi:10.1182/hematology.2023000486 · Cited by 12
Franceschi, L. D., Locatelli, F., Rees, D. C., Chabannon, C., Dalle, J., Rivella, S., Iolascon, A., Lobitz, S., Abboud, M. R., de la Fuente, J., et al. (2025) · HemaSphere · doi:10.1002/hem3.70089 · Cited by 15
Fox, B. D., Okumiya, T., Attas-Fox, L., Kassirer, M., Raviv, Y., & Kramer, M. R. (2012) · Respiratory Medicine · doi:10.1016/j.rmed.2011.12.005 · Cited by 11
The different facets of sickle cell disease-related pulmonary hypertension
Prohaska, C. C., & Machado, R. F. (2021) · Current Opinion in Pulmonary Medicine · doi:10.1097/mcp.0000000000000795 · Cited by 11
Schimmel, M., van Beers, E. J., Tuijn, C. F. J. V., Nur, E., Rijneveld, A. W., Gillavry, M. R. M., Brandjes, D. P. M., Schnog, J. B., Biemond, B. J., & on behalf of the CURAMA study group (2015) · American Journal of Hematology · doi:10.1002/ajh.23944 · Cited by 14
Acute chest syndrome in sickle cell disease
Laurie, G. (2010) · Internal Medicine Journal · doi:10.1111/j.1445-5994.2010.02129.x · Cited by 13
Vasconcelos, M. C. M., Nunes, M. C. P., Barbosa, M. M., Fernandes, B. M., Passaglia, L. G., Silva, C. M., & Ferrari, T. C. A. (2015) · Annals of Hematology · doi:10.1007/s00277-015-2430-z · Cited by 11
Gladwin, M. T. (2011) · Expert Review of Hematology · doi:10.1586/ehm.11.66 · Cited by 11
Self-citationAgha, H. M., Eltagui, M. H., El-Ghamrawy, M., & Elhady, M. A. (2014) · Annals of Hematology · doi:10.1007/s00277-014-2030-3 · Cited by 11
Ojewunmi, O. O., Adeyemo, T. A., Osuntoki, A. A., Imaga, N. A., & Oyetunji, A. I. (2017) · Paediatrics and International Child Health · doi:10.1080/20469047.2017.1311087 · Cited by 12
Applications of cardiac magnetic resonance imaging in sickle cell disease
Niss, O., & Taylor, M. D. (2017) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2017.08.005 · Cited by 10
Powell, A. W., Alsaied, T., Niss, O., Fleck, R. J., Malik, P., Quinn, C. T., Mays, W. A., Taylor, M. D., & Chin, C. C. (2019) · Pediatric Blood & Cancer · doi:10.1002/pbc.27703 · Cited by 11
Optimizing Hydroxyurea Treatment for Sickle Cell Disease Patients: The Pharmacokinetic Approach
Nazon, C., Sabo, A.-N., Becker, G., Lessinger, J., Kemmel, V., & Paillard, C. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8101701 · Cited by 11
Groshong, S. D., Tomashefski, J. F., & Cool, C. D. (2008) · Springer eBooks · doi:10.1007/978-0-387-68792-6_28 · Cited by 11
de Araújo, C. G., Resende, M. B. S., Tupinambás, J. T., Dias, R. C. T. M., Barros, F. C., Vasconcelos, M. C. M., Januário, J. N., Ribeiro, A. L. P., & Nunes, M. C. P. (2022) · Arquivos Brasileiros de Cardiologia · doi:10.36660/abc.20200437 · Cited by 11
Krishnamurti, L., Lanford, L. M., & Munoz, R. A. (2006) · Pediatric Blood & Cancer · doi:10.1002/pbc.20855 · Cited by 11
Gingo, M. R., Zhang, Y., Ghebrehawariat, K., Jeong, J., Chu, Y., Yang, Q., Lucht, L. A., Hanna, D. B., Lazar, J., Gladwin, M. T., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0123389 · Cited by 12
Self-citationShilo, N. R., & Morris, C. R. (2017) · Expert Review of Hematology · doi:10.1080/17474086.2017.1364989 · Cited by 13
Hooper, W. C., Mensah, G. A., Haworth, S. G., Black, S. M., Garcia, J. G. N., & Langleben, D. (2006) · Vascular Pharmacology · doi:10.1016/j.vph.2006.10.017 · Cited by 11
Duffy-negative is associated with hemolytic phenotype of sickle cell anemia
Mecabô, G., HAYASHIDA, D. Y., Shimmoto, M. M. A., Vicari, P., Arruda, M. M. D. A. S., Bordin, J. O., & Figueiredo, M. S. (2010) · Clinical Immunology · doi:10.1016/j.clim.2010.06.006 · Cited by 60
The Need for National Registries in Rare Diseases
Souza, R., Jardim, C., & de Carvalho, C. R. R. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.174.2.228 · Cited by 11
Autosplenectomy may be a good prognostic sign in sickle cell diseases
Helvacı, M. R., Tuncsezen, U. K., Varol, A., Onay, K., Davran, R., Yaprak, M., Abyad, A., & Pocock, L. (2023) · World Family Medicine Journal/Middle East Journal of Family Medicine · doi:10.5742/mewfm.2023.95256177 · Cited by 10
Chatzidavid, S., Flevari, P., Tombrou, I., Anastasiadis, G., & Dimopoulou, M. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25094792 · Cited by 12
Placenta growth factor mediated gene regulation in sickle cell disease
Kalra, V. K., Zhang, S., Malik, P., & Tahara, S. M. (2017) · Blood Reviews · doi:10.1016/j.blre.2017.08.008 · Cited by 10
Cardiac manifestations in sickle cell disease varies with patient genotype
Guedeney, P., Lionnet, F., Ceccaldi, A., Stankovic, K., Cohen, A. A., Mattioni, S., Montalescot, G., Bachmeyer, C., Isnard, R., Haymann, J., et al. (2018) · British Journal of Haematology · doi:10.1111/bjh.15238 · Cited by 10
Njoku, F. U., Zhang, X., Shah, B. N., Machado, R. F., Han, J., Saraf, S. L., & Gordeuk, V. R. (2021) · British Journal of Haematology · doi:10.1111/bjh.17682 · Cited by 12
Tricuspid regurgitant jet velocity and hospitalization in Tanzanian children with sickle cell anemia
Cox, S. E., Soka, D., Kirkham, F. J., Newton, C. R. J. C., Prentice, A. M., Makani, J., & Younoszai, A. K. (2014) · Haematologica · doi:10.3324/haematol.2013.089235 · Cited by 11
Vlachaki, E., Kalogeridis, A., Neokleous, N., Perifanis, V., Klonizakis, P., Ioannidou, E.-D., & Klonizakis, I. (2011) · Molecular Biology Reports · doi:10.1007/s11033-011-1425-7 · Cited by 10
Quimby, K. R., Moe, S., Sealy, I., Nicholls, C., Hambleton, I. R., & Landis, R. C. (2014) · BMC Research Notes · doi:10.1186/1756-0500-7-102 · Cited by 11
The clinical care of adult patients with sickle cell disease
Olujohungbe, A., & Howard, J. (2008) · British Journal of Hospital Medicine · doi:10.12968/hmed.2008.69.11.31646 · Cited by 11
Rivell, G. L., Brunson, C. Y., Milligan, L., Stuart, R. K., & Costa, L. J. (2011) · American Journal of Hematology · doi:10.1002/ajh.22054 · Cited by 11
Genetic Factors Modifying Sickle Cell Disease Severity
Gardner, K., & Thein, S. L. (2016) · Springer eBooks · doi:10.1007/978-3-319-06713-1_15 · Cited by 14
Severe Hemolysis and Pulmonary Hypertension in a Neonate With Upshaw–Schulman Syndrome
Tsujii, N., Shiraishi, I., Kokame, K., Shima, M., Fujimura, Y., Takahashi, Y., & Matsumoto, M. (2016) · PEDIATRICS · doi:10.1542/peds.2016-1565 · Cited by 10
Cardiomyopathy in Sickle Cell Disease
Kaur, H., Aurif, F., Kittaneh, M., Chio, J. P. G., & Malik, B. H. (2020) · Cureus · doi:10.7759/cureus.9619 · Cited by 17
Cramer‐Bour, C., Ruhl, A. P., Nouraie, M. S., Emeh, R. O., Ruopp, N. F., Thein, S. L., Weir, N. A., & Klings, E. S. (2021) · European Journal Of Haematology · doi:10.1111/ejh.13612 · Cited by 11
Allogeneic hematopoietic stem cell transplant for sickle cell disease: The why, who, and what
Cimpeanu, E., Poplawska, M., Jimenez, B. C., Dutta, D., & Lim, S. H. (2021) · Blood Reviews · doi:10.1016/j.blre.2021.100868 · Cited by 12
Endothelial dysfunction and hypercoagulability in severe sickle-cell acute chest syndrome
Jutant, E., Voiriot, G., Labbé, V., Savale, L., Mokrani, H., Dreden, P. V., Gerotziafas, G., & Fartoukh, M. S. (2021) · ERJ Open Research · doi:10.1183/23120541.00496-2021 · Cited by 11
Dyspnea, pulmonary function and exercise capacity in adult Saudi patients with sickle cell disease
Alameri, H. F., Aleem, A., Kardas, W., Jehangir, A., Owais, M., & Al-Momen, A. (2008) · Saudi Medical Journal · doi:10.15537/1658-3175.4328 · Cited by 15
Pack-Mabien, A. V., Brown, B. A., Herbert, D. E., & Haynes, J. (2015) · Journal of the American Association of Nurse Practitioners · doi:10.1002/2327-6924.12221 · Cited by 10
Self-citationSaleemi, S. (2014) · Annals of Thoracic Medicine · doi:10.4103/1817-1737.134039 · Cited by 13
Deonikar, P., & Kavdia, M. (2012) · Journal of Applied Physiology · doi:10.1152/japplphysiol.01173.2011 · Cited by 11
Saramba, M. I., Shakya, S., & Zhao, D. (2019) · Jornal de Pediatria · doi:10.1016/j.jped.2019.05.004 · Cited by 13
Cho, G., & Hambleton, I. R. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008360.pub3 · Cited by 12
Gibson, J. S., & Rees, D. C. (2023) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2023.2179484 · Cited by 12
Metadata
- Authors
- Gladwin, M. T., Sachdev, V., Jison, M. L., Shizukuda, Y., Plehn, J. F., Minter, K., Brown, B., Coles, W. A., Nichols, J. S., Ernst, I., Hunter, L. A., Blackwelder, W. C., Schechter, A. N., Rodgers, G. P., Castro, O., & Ognibene, F. P.
- Affiliations
- National Institutes of Health (US)
- National Heart, Lung, and Blood Institute (US)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2004-02-26
- Volume
- 350
- Issue
- 9
- Pages
- 886-895
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2148547093
- Cited by
- 1,325
- References
- 42
- Citations by year
- 2026: 42 · 2025: 30 · 2024: 45 · 2023: 44 · 2022: 42 · 2021: 47 · 2020: 34 · 2019: 61 · 2018: 43 · 2017: 57 · 2016: 74 · 2015: 64 · 2014: 76 · 2013: 64 · 2012: 68
- FWCI
- 35.46
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Digital Howard (Howard University) (submittedVersion)
- Topics
- Health Sciences › Medicine › Genetics (clinical) › Hemoglobinopathies and Related Disorders
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Pulmonary Hypertension Research and Treatments
- Health Sciences › Medicine › Rheumatology › Systemic Sclerosis and Related Diseases
- Keywords
- pulmonary hypertension, sickle cell disease, mortality risk, tricuspid regurgitation velocity, Doppler echocardiography, chronic hemolysis, hydroxyurea therapy, risk factors, alkaline phosphatase, lactate dehydrogenase, transferrin, cardiovascular complications, renal complications
- MeSH terms
- Adult, Anemia, Sickle Cell, Antisickling Agents, Blood Pressure, Cause of Death, Drug Resistance, Female, Hemolysis, Humans, Hydroxyurea, Hypertension, Pulmonary, Male, Pulmonary Artery, Risk Factors, Tricuspid Valve Insufficiency, Echocardiography, Doppler, Prevalence, Survival Rate, Logistic Models, Ventricular Function
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.